Tissue factor pathway inhibitor-2 is induced by fluid shear stress in vascular smooth muscle cells and affects cell proliferation and survival

Journal of Vascular Surgery

Volumn 52, Issue 1, 2010, Pages 167-175

  Ekstrand, Johan ^a   Razuvaev, Anton ^a   Folkersen, Lasse ^a   Roy, Joy ^a   Hedin, Ulf ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; MESSENGER RNA; PLACENTA PROTEIN 5;

ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CAROTID ARTERY; CELL CYCLE REGULATION; CELL FUNCTION; CELL GROWTH; CELL PROLIFERATION; CELL SURVIVAL; COMPARATIVE STUDY; CONTROLLED STUDY; DNA SYNTHESIS; ENZYME ACTIVATION; ENZYME LOCALIZATION; GENE CONTROL; GENE EXPRESSION; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; INTIMA; MALE; MICROARRAY ANALYSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; SHEAR STRESS; SMOOTH MUSCLE FIBER; UPREGULATION; VASCULAR SMOOTH MUSCLE;

ANIMALS; APOPTOSIS; CAROTID ARTERY INJURIES; CASPASE 3; CELL PROLIFERATION; CELL SURVIVAL; CELLS, CULTURED; DISEASE MODELS, ANIMAL; DNA REPLICATION; GENE EXPRESSION PROFILING; GLYCOPROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RATS; RATS, SPRAGUE-DAWLEY; RECOMBINANT PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; STRESS, MECHANICAL; TIME FACTORS; UP-REGULATION;

EID: 77953684517     PISSN: 07415214     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jvs.2010.02.282     Document Type: Article

References (40)

1. Ziegler T., Silacci P., Harrison V.J., and Hayoz D. Nitric oxide synthase expression in endothelial cells exposed to mechanical forces. Hypertension 32 (1998) 351-355
2. Scholz D., Ito W., Fleming I., Deindl E., Sauer A., Wiesnet M., et al. Ultrastructure and molecular histology of rabbit hind-limb collateral artery growth (arteriogenesis). Virchows Arch 436 (2000) 257-270
3. Chiu J.J., Usami S., and Chien S. Vascular endothelial responses to altered shear stress: pathologic implications for atherosclerosis. Ann Med 41 (2009) 19-28
4. Yoshizumi M., Abe J., Tsuchiya K., Berk B.C., and Tamaki T. Stress and vascular responses: atheroprotective effect of laminar fluid shear stress in endothelial cells: possible role of mitogen-activated protein kinases. J Pharmacol Sci 91 (2003) 172-176
5. Tada S., and Tarbell J.M. Flow through internal elastic lamina affects shear stress on smooth muscle cells (3D simulations). Am J Physiol Heart Circ Physiol 282 (2002) H576-H584
6. Acampora K.B., Langan III E.M., Miller R.S., and Laberge M. Development of a novel vascular simulator and injury model to evaluate smooth muscle cell response following balloon angioplasty. Ann Vasc Surg 21 (2007) 734-741
7. Hedin U., Roy J., and Tran P.K. Control of smooth muscle cell proliferation in vascular disease. Curr Opin Lipidol 15 (2004) 559-565
8. Weintraub W.S. The pathophysiology and burden of restenosis. Am J Cardiol 100 (2007) 3K-9K
9. Morice M.C., Serruys P.W., Sousa J.E., Fajadet J., Ban Hayashi E., Perin M., et al. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 346 (2002) 1773-1780
10. Luscher T.F., Steffel J., Eberli F.R., Joner M., Nakazawa G., Tanner F.C., et al. Drug-eluting stent and coronary thrombosis: biological mechanisms and clinical implications. Circulation 115 (2007) 1051-1058
11. Sterpetti A.V., Cucina A., D'Angelo L.S., Cardillo B., and Cavallaro A. Shear stress modulates the proliferation rate, protein synthesis, and mitogenic activity of arterial smooth muscle cells. Surgery 113 (1993) 691-699
12. Fitzgerald T.N., Shepherd B.R., Asada H., Teso D., Muto A., Fancher T., et al. Laminar shear stress stimulates vascular smooth muscle cell apoptosis via the Akt pathway. J Cell Physiol 216 (2008) 389-395
13. Hahn C., and Schwartz M.A. The role of cellular adaptation to mechanical forces in atherosclerosis. Arterioscler Thromb Vasc Biol 28 (2008) 2101-2107
14. Chatzizisis Y.S., Coskun A.U., Jonas M., Edelman E.R., Feldman C.L., and Stone P.H. Role of endothelial shear stress in the natural history of coronary atherosclerosis and vascular remodeling: molecular, cellular, and vascular behavior. J Am Coll Cardiol 49 (2007) 2379-2393
15. Frangos J.A., McIntire L.V., and Eskin S.G. Shear stress induced stimulation of mammalian cell metabolism. Biotechnol Bioeng 32 (1988) 1053-1060
16. Roy J., Tran P.K., Religa P., Kazi M., Henderson B., Lundmark K., et al. Fibronectin promotes cell cycle entry in smooth muscle cells in primary culture. Exp Cell Res 273 (2002) 169-177
17. Luo W., Friedman M.S., Shedden K., Hankenson K.D., and Woolf P.J. GAGE: generally applicable gene set enrichment for pathway analysis. BMC Bioinformatics 10 (2009) 161
18. Ashburner M., Ball C.A., Blake J.A., Botstein D., Butler H., Cherry J.M., et al. Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat Genet 25 (2000) 25-29
19. Wang H., Yan S., Chai H., Riha G.M., Li M., Yao Q., et al. Shear stress induces endothelial transdifferentiation from mouse smooth muscle cells. Biochem Biophys Res Commun 346 (2006) 860-865
20. Bohn H., and Winckler W. [Isolation and characterization of the placental protein pp5 (author's transl)]. Arch Gynakol 223 (1977) 179-186
21. Kisiel W., Sprecher C.A., and Foster D.C. Evidence that a second human tissue factor pathway inhibitor (TFPI-2) and human placental protein 5 are equivalent. Blood 84 (1994) 4384-4385
22. Chand H.S., Foster D.C., and Kisiel W. Structure, function and biology of tissue factor pathway inhibitor-2. Thromb Haemost 94 (2005) 1122-1130
23. Crawley J.T., Goulding D.A., Ferreira V., Severs N.J., and Lupu F. Expression and localization of tissue factor pathway inhibitor-2 in normal and atherosclerotic human vessels. Arterioscler Thromb Vasc Biol 22 (2002) 218-224
24. Butzow R., Alfthan H., Stenman U.H., Suikkari A.M., Bohn H., and Seppala M. Immunofluorometric demonstration and quantification of placental protein 5 in the absence of pregnancy. Clin Chem 34 (1988) 1591-1593
25. Xu Z., Maiti D., Kisiel W., and Duh E.J. Tissue factor pathway inhibitor-2 is upregulated by vascular endothelial growth factor and suppresses growth factor-induced proliferation of endothelial cells. Arterioscler Thromb Vasc Biol 26 (2006) 2819-2825
26. Herman M.P., Sukhova G.K., Kisiel W., Foster D., Kehry M.R., Libby P., et al. Tissue factor pathway inhibitor-2 is a novel inhibitor of matrix metalloproteinases with implications for atherosclerosis. J Clin Invest 107 (2001) 1117-1126
27. Du X., Chand H.S., and Kisiel W. Human tissue factor pathway inhibitor-2 does not bind or inhibit activated matrix metalloproteinase-1. Biochim Biophys Acta 1621 (2003) 242-245
28. Petersen L.C., Sprecher C.A., Foster D.C., Blumberg H., Hamamoto T., and Kisiel W. Inhibitory properties of a novel human Kunitz-type protease inhibitor homologous to tissue factor pathway inhibitor. Biochemistry 35 (1996) 266-272
29. Meisser A., Bischof P., and Bohn H. Placental protein 5 (PP5) inhibits thrombin-induced coagulation of fibrinogen. Arch Gynecol 236 (1985) 197-201
30. Sprecher C.A., Kisiel W., Mathewes S., and Foster D.C. Molecular cloning, expression, and partial characterization of a second human tissue-factor-pathway inhibitor. Proc Natl Acad Sci U S A 91 (1994) 3353-3357
31. Grabowski E.F., Reininger A.J., Petteruti P.G., Tsukurov O., and Orkin R.W. Shear stress decreases endothelial cell tissue factor activity by augmenting secretion of tissue factor pathway inhibitor. Arterioscler Thromb Vasc Biol 21 (2001) 157-162
32. Westmuckett A.D., Lupu C., Roquefeuil S., Krausz T., Kakkar V.V., and Lupu F. Fluid flow induces upregulation of synthesis and release of tissue factor pathway inhibitor in vitro. Arterioscler Thromb Vasc Biol 20 (2000) 2474-2482
33. Kohler T.R., and Jawien A. Flow affects development of intimal hyperplasia after arterial injury in rats. Arterioscler Thromb 12 (1992) 963-971
34. Yan Z.Q., Yokota T., Zhang W., and Hansson G.K. Expression of inducible nitric oxide synthase inhibits platelet adhesion and restores blood flow in the injured artery. Circ Res 79 (1996) 38-44
35. Bochaton-Piallat M.L., Gabbiani F., Redard M., Desmouliere A., and Gabbiani G. Apoptosis participates in cellularity regulation during rat aortic intimal thickening. Am J Pathol 146 (1995) 1059-1064
36. Mattsson E.J., Kohler T.R., Vergel S.M., and Clowes A.W. Increased blood flow induces regression of intimal hyperplasia. Arterioscler Thromb Vasc Biol 17 (1997) 2245-2249
37. Sierko E., Wojtukiewicz M.Z., and Kisiel W. The role of tissue factor pathway inhibitor-2 in cancer biology. Semin Thromb Hemost 33 (2007) 653-659
38. George J., Gondi C.S., Dinh D.H., Gujrati M., and Rao J.S. Restoration of tissue factor pathway inhibitor-2 in a human glioblastoma cell line triggers caspase-mediated pathway and apoptosis. Clin Cancer Res 13 (2007) 3507-3517
39. Shinoda E., Yui Y., Hattori R., Tanaka M., Inoue R., Aoyama T., et al. Tissue factor pathway inhibitor-2 is a novel mitogen for vascular smooth muscle cells. J Biol Chem 274 (1999) 5379-5384
40. Du X., Deng F.M., Chand H.S., and Kisiel W. Molecular cloning, expression, and characterization of bovine tissue factor pathway inhibitor-2. Arch Biochem Biophys 417 (2003) 96-104